Sigma Investment Counselors’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$31.4K	Hold	28,000	–	–	﹤0.01%	196
2025 Q1	$27.2K	Hold	28,000	–	–	﹤0.01%	187
2024 Q4	$32.8K	Sell	28,000 -2,000	-7%	-$2.34K	﹤0.01%	197
2024 Q3	$50.4K	Buy	+30,000	New	+$50.4K	﹤0.01%	198